EX-10.23 27 dex1023.htm AMENDMENT NO. 9 TO LEASE AND LICENSE AGREEMENT, DATED 04/30/2009 Amendment No. 9 to Lease and License Agreement, dated 04/30/2009

Exhibit 10.23

MARYLAND TECHNOLOGY DEVELOPMENT CENTER

LICENSE AGREEMENT

AMENDMENT 9

This addendum is made this 30 day of April, 2009, by and between MEDCO and Neogenix Oncology, Inc. (“Licensee”).

WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;

WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #132, #261, #262, #267 and #317 in the Maryland Technology Development Center in Montgomery County, Maryland (the “Original Premises”);

WHEREAS Licensee wishes to reduce its office space within the Maryland Technology Development Center and MEDCO is willing to provide for such reduction based on the terms provided for below;

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows:

 

  1. Effective May 31, 2009, Licensee shall vacate office #132 (the “Reduction Premises”).

 

  2. The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows:

 

From June 1, 2009 to April 30, 2010

    $ 10,161

Renewal Term (if granted by MEDCO) From June 1, 2010 to April 30, 2011

    $ 11,177

 

  3. All other provisions of the original License Agreement shall apply to this Amendment

This Amendment may be signed in counterparts.

 

FOR:

  

Maryland Economic

Development Corporation

     FOR:   Neogenix Oncology, Inc.

BY:

  

/s/ Robyn Sanches

     BY:  

LOGO

 

Scheer Partners, Inc.

Center Manager

      

Date:

   5/22/09     Date:   4/30/09

BY:

  

/s/ Robert C. Brennan

      
 

Robert C. Brennan

Executive Director, MEDCO

      

Date:

   6/3/09